Boost for curved spine treatment

The new Magec system does not require periodical surgical incisions to lengthen the rods
28 January 2014

Children with curved spines could soon be treated with remote-controlled rods attached to their spines.

The NHS could offer youngsters with scoliosis the new treatment after the National Institute for Health and Care Excellence supported its use in draft guidance.

Extendable titanium rods are attached to the ribs or spine of the child near to the curved section of the spine in a similar way to the implantation of conventional rods.

The new Magec (Mag netic Expansion Control) system does not require periodical surgical incisions to lengthen the rods but instead uses a remote device, which controls magnets in the rod to adjust its length.

This means the child will not have to undergo general anaesthetic and can have their rods altered in an outpatient clinic.

In new draft guidance, Nice has supported the use of the Magec system in children with scoliosis aged two to 11. But it only recommends the device if conventional methods such a back brace have not worked.

Professor Carole Longson, director of Nice's Centre for Health Technology Evaluation, said: "For children who need treatment for scoliosis, and for whom standard treatment such as a back brace hasn't worked, surgery to implant conventional growth rods is an option. But the repeated surgical procedures that are needed to extend the rods can be difficult for the child and their family or carers, and can cause distress.

"In this draft guidance, the independent medical technologies advisory committee considered that there was evidence to support the use of the Magec system to help straighten and lengthen the spine in children aged between two and 11 years.

"By avoiding the need for the repeated surgical procedures, the committee accepted claims that the device can reduce the incidence of surgical complications and infections, cause less pain and distress and less time away from school.

"The use of Magec was estimated to potentially save the NHS around £12,000 per patient after six years compared with using conventional growth rods."

The Nice guidance is now open for consultation.

Create a FREE account to continue reading

eros

Registration is a free and easy way to support our journalism.

Join our community where you can: comment on stories; sign up to newsletters; enter competitions and access content on our app.

Your email address

Must be at least 6 characters, include an upper and lower case character and a number

You must be at least 18 years old to create an account

* Required fields

Already have an account? SIGN IN

By clicking Create Account you confirm that your data has been entered correctly and you have read and agree to our Terms of use , Cookie policy and Privacy policy .

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged in